Immediate Impact

1 by Nobel laureates 57 standout
Sub-graph 1 of 23

Citing Papers

The anti-PD-L1/CTLA-4 bispecific antibody KN046 plus lenvatinib in advanced unresectable or metastatic hepatocellular carcinoma: a phase II trial
2025 Standout
Targeting the tumour vasculature: from vessel destruction to promotion
2024 Standout
2 intermediate papers

Works of Barbara J. Biller being referenced

Low-Dose Cyclophosphamide Selectively Decreases Regulatory T Cells and Inhibits Angiogenesis in Dogs with Soft Tissue Sarcoma
2011
Use of FoxP3 expression to identify regulatory T cells in healthy dogs and dogs with cancer
2006

Author Peers

Author Last Decade Papers Cites
Barbara J. Biller 553 350 293 28 1000
Isabella W.Y. Mak 241 127 81 18 1.2k
Brenda Cohen 124 242 88 35 1.3k
Christina Mazcko 593 216 402 32 1.1k
Robyn Elmslie 832 433 452 29 1.3k
Milcah C. Scott 335 626 212 29 1.3k
W W Johnston 384 169 41 42 1.2k
Elizabeth Feldman 106 178 64 29 961
Constance A. Stanton 153 92 66 39 1.2k
Howard B. Urnovitz 148 183 88 40 944
Frédérique Ponce 819 163 328 34 1.0k

All Works

Loading papers...

Rankless by CCL
2026